Anthony S. Fiorino is CEO at BRAINSTORM CELL THERAPEUTICS INC. (BCLI). They have made 5 open-market trades across 2 companies since 2014, most recently 2018-05-22.
CIK 0001608901
5 open-market purchases totalling $29K since 2014, never a sale. Across 5 scored buys the stock is down 6.9% at thirty days, and 7.5 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 60% | — |
| Avg Move | -24.1% | -6.9% | — |
| Alpha | -20.6% | -7.5% | — |
| Scored | 5 | 5 | 3 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMNP | BUY | 2018-05-22 | 2018-05-23 | $0.24 | $6K | -6.8% | -25.2% | N/A |
| IMNP | BUY | 2018-05-17 | 2018-05-18 | $0.26 | $13K | -15.2% | -18.7% | N/A |
| BCLI | BUY | 2014-10-15 | 2014-10-15 | $3.60 | $2K | -32.9% | +3.1% | +3.1% |
| BCLI | BUY | 2014-09-18 | 2014-09-19 | $3.84 | $3K | -32.9% | +3.1% | +3.1% |
| BCLI | BUY | 2014-09-12 | 2014-09-16 | $0.29 | $5K | -32.9% | +3.1% | +3.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.